Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Total 13F shares
-
25,186,221
-
Share change
-
+4,376,976
-
Total reported value
-
$418,084,441
-
Put/Call ratio
-
95%
-
Price per share
-
$16.60
-
Number of holders
-
97
-
Value change
-
+$68,372,247
-
Number of buys
-
73
-
Number of sells
-
32
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2017
As of 31 Dec 2017,
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,186,221 shares.
The largest 10 holders included
TRV GP III, LLC, FMR LLC, BB BIOTECH AG, BlackRock Inc., Casdin Capital, LLC, Vanguard Group Inc, EVENTIDE ASSET MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., FARALLON CAPITAL MANAGEMENT LLC, and Laurion Capital Management LP.
This page lists
97
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.